Literature DB >> 22335489

Unplanned pregnancy and contraceptive use in women attending drug treatment services.

Kirsten I Black1, Christine Stephens, Paul S Haber, Nicholas Lintzeris.   

Abstract

BACKGROUND: At an international level, there are calls for a greater focus on women and harm reduction in recognition that female drug users have a unique set of issues that are not routinely assessed in drug treatment programs. AIMS: To assess the pregnancy history, current pregnancy risk and contraceptive use of nonpregnant women attending opioid treatment programs (OTPs).
METHODS: This study involved a structured questionnaire survey of 204 women attending outpatient OTP services within the Sydney South West Area Health Service.
RESULTS: Two hundred and four women of 302 (67.5%) enroled in OTPs at the time completed surveys. Key findings were high pregnancy rates, with 28.9% of women reporting six or more pregnancies, high rates of adverse pregnancy outcomes (miscarriage, termination and stillbirth) compared with national data and poor uptake of contraception, with only 54.7% of sexually active women not wanting to get pregnant using a method. Women expressed diverse preferences for the type and location of women's health services they felt would meet their needs.
CONCLUSION: Women in OTP clinics have unaddressed reproductive health issues, particularly around contraception. Addressing these will potentially minimise the risk of material deprivation and social exclusion in these women and improve their well-being through greater control and choice over their fertility. Current women's health service provision in OTP programs involves referral to external services, but an integrated model of care may best address the unmet contraceptive needs of these women.
© 2012 The Authors ANZJOG © 2012 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22335489     DOI: 10.1111/j.1479-828X.2012.01413.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  29 in total

1.  Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder.

Authors:  Alexis K Matusiewicz; Heidi S Melbostad; Sarah H Heil
Journal:  Contraception       Date:  2017-08-02       Impact factor: 3.375

Review 2.  Contraceptive use and method choice among women with opioid and other substance use disorders: A systematic review.

Authors:  Mishka Terplan; Dennis J Hand; Melissa Hutchinson; Elizabeth Salisbury-Afshar; Sarah H Heil
Journal:  Prev Med       Date:  2015-04-18       Impact factor: 4.018

Review 3.  Adolescent substance use and unplanned pregnancy: strategies for risk reduction.

Authors:  Hilary Smith Connery; Brittany B Albright; John M Rodolico
Journal:  Obstet Gynecol Clin North Am       Date:  2014-04-06       Impact factor: 2.844

4.  Postpartum contraceptive use and interpregnancy interval among women with opioid use disorder.

Authors:  Elizabeth E Krans; Joo Yeon Kim; Alton Everette James; David K Kelley; Marian Jarlenski
Journal:  Drug Alcohol Depend       Date:  2018-02-14       Impact factor: 4.492

5.  Innovative approaches to reduce unintended pregnancy and improve access to contraception among women who use opioids.

Authors:  Sarah H Heil; Heidi S Melbostad; Catalina N Rey
Journal:  Prev Med       Date:  2019-08-06       Impact factor: 4.018

6.  Prenatal intent and postpartum receipt of long-acting reversible contraception among women receiving medication-assisted treatment for opioid use disorder.

Authors:  Anupama Kotha; Beatrice A Chen; Lauren Lewis; Shannon Dunn; Katherine P Himes; Elizabeth E Krans
Journal:  Contraception       Date:  2018-08-13       Impact factor: 3.375

7.  The impact of Medicaid expansion on postpartum health care utilization among pregnant women with opioid use disorder.

Authors:  Briana P Patton; Elizabeth E Krans; Joo Yeon Kim; Marian Jarlenski
Journal:  Subst Abus       Date:  2019-03-25       Impact factor: 3.716

8.  Using behavioral economic theory to increase use of effective contraceptives among opioid-maintained women at risk of unintended pregnancy.

Authors:  Sarah H Heil; Dennis J Hand; Stacey C Sigmon; Gary J Badger; Marjorie C Meyer; Stephen T Higgins
Journal:  Prev Med       Date:  2016-06-23       Impact factor: 4.018

Review 9.  Buprenorphine use in pregnant opioid users: a critical review.

Authors:  Michael Soyka
Journal:  CNS Drugs       Date:  2013-08       Impact factor: 5.749

10.  Examining delay discounting of condom-protected sex among opioid-dependent women and non-drug-using control women.

Authors:  Evan S Herrmann; Dennis J Hand; Matthew W Johnson; Gary J Badger; Sarah H Heil
Journal:  Drug Alcohol Depend       Date:  2014-07-30       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.